# Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion

> **NCT02739685** · NA · TERMINATED · sponsor: **University of Luebeck** · enrollment: 17 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Everolimus-eluting bioresorbable vascular scaffold
- **DEVICE:** Everolimus-eluting stent

## Key facts

- **NCT ID:** NCT02739685
- **Lead sponsor:** University of Luebeck
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Slow enrollment, access to devices
- **Last updated:** 2019-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02739685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02739685, "Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02739685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*